Artera Crowned #1 in Patient Communications by KLAS Amid AI Boom

SANTA BARBARA, Calif. – February 27, 2026 – Artera, a company at the forefront of combining human and artificial intelligence for healthcare, has been named the #1 Best in KLAS for Patient Communications in the prestigious 2026 Best in KLAS Awards. The recognition, based on direct and comprehensive feedback from healthcare providers, signals a significant industry endorsement for the power of AI in solving persistent administrative challenges and improving the patient experience.

With an overall performance score of 89.8, Artera earned straight A- grades across all six of KLAS Research's rigorous evaluation categories: Culture, Loyalty, Operations, Product, Relationship, and Value. This clean sweep, derived from evaluations by more than 20 healthcare organizations, distinguishes the company in a crowded and competitive market, validating a decade-long mission to streamline how providers and patients connect.

A Validation of AI's Role in Healthcare

This Best in KLAS award arrives at a pivotal moment for healthcare, an industry grappling with severe staffing shortages and administrative burnout. Artera's win is seen by many analysts not just as a corporate victory, but as a broader validation of 'agentic AI'—intelligent systems that can autonomously manage complex tasks—as a viable and effective solution. The company has moved beyond simple reminders, deploying a sophisticated suite of Virtual Agent solutions designed to offload administrative work and improve patient access to care.

Central to this success are Artera's Flows Agents, which now manage over 42 million unique patient conversations annually. According to company data, these agents successfully complete an impressive 94 percent of these interactions without any human staff intervention. This high rate of autonomy provides a clear pathway for healthcare systems to automate routine communications, freeing up staff to focus on more complex, high-touch patient needs. The tangible impact is a claimed savings of millions of staff hours across their client base.

Further augmenting this are the AI Co-Pilots, which have been deployed by over 100 healthcare providers. These tools work directly alongside human staff, accelerating response times by summarizing long conversation threads and automating message composition. This human-AI collaboration is a cornerstone of Artera's philosophy, aiming to enhance, not replace, the human element in healthcare.

"A decade ago, we set out to fix patient communications; ten years later, we are still setting the industry standard," said Guillaume de Zwirek, CEO and Co-founder of Artera. "As we lead the industry toward an 'agentic' future, these scores validate that we remain a steadfast partner, delivering the fundamental reliability and measurable value our customers expect from us every day."

Standing Out in a Competitive Field

Artera's ascent to the top KLAS ranking is particularly noteworthy given the dynamic nature of the patient communications market. The company outperformed a field of established and emerging players, including Luma Health, which is also recognized for its mature texting functionality, and RevSpring, the category's #1 winner in 2024. The 2026 report also highlighted TeleVox as a "Most Improved" vendor, indicating that competition remains fierce and customer expectations are continually rising.

KLAS Research is highly regarded because its rankings are not based on analyst opinion but on direct, verified feedback from the healthcare professionals who use these systems daily. For a vendor to be ranked, it must have a significant number of validated clients, ensuring the results reflect real-world performance. Artera's A- grades in categories like Relationship and Value suggest that customers see the company not just as a technology vendor, but as a strategic partner invested in their success.

"These 'straight A-' grades are a tribute to our entire team at Artera, but in particular our Implementation, Support, and Customer Success teams, who work tirelessly as a true partner to our customers," stated Tom McIntyre, President of Artera. He emphasized that the recognition validates that the company delivers "a world-class, end-to-end customer service experience that healthcare providers can trust."

Financial Momentum and Strategic Growth

Underpinning Artera's technological and market success is a period of significant financial momentum. The company recently secured a $65 million growth investment specifically to accelerate the adoption of its agentic AI platform. This infusion of capital followed a major business milestone: surpassing $100 million in Contracted Annual Recurring Revenue (CARR). These figures paint a picture of a company not only innovating but also scaling effectively.

This financial strength is the result of sustained performance over many years. Artera has been a consistent presence on both the Deloitte Technology Fast 500 and Inc. 5000 lists of fastest-growing companies for five and six consecutive years, respectively. Serving over 1,000 healthcare organizations—from small specialty groups to large Integrated Delivery Networks (IDNs) and federal agencies—the platform now handles more than 2 billion patient communications annually.

Building Trust with a Security-First Approach

As AI becomes more integrated into clinical and administrative workflows, questions around data security and patient privacy have become paramount. Artera has addressed these concerns head-on, building its platform on a foundation of robust security protocols. The company's solutions are HITRUST Certified, SOC 2 Type 2 compliant, and meet all HIPAA requirements for handling sensitive patient data.

Crucially, Artera has publicly stated that it does not use Protected Health Information (PHI) or Personally Identifiable Information (PII) to train its AI models. This is a critical distinction in the healthcare AI space, as it mitigates significant privacy risks and builds trust with providers and patients alike. By de-identifying data used for system improvement, the company can enhance its AI capabilities without compromising patient confidentiality, a practice that aligns with the highest industry standards and addresses a key point of hesitation for many healthcare leaders considering AI adoption.

With this Best in KLAS recognition, Artera has cemented its position as a leader in the evolution of patient communications. The award serves as a powerful testament from its own customers that the company's blend of advanced AI, strong security, and a partnership-focused approach is delivering measurable value and defining the future of patient engagement in a rapidly changing healthcare landscape.